BioSpectrum Asia - May 2022Add to Favorites

BioSpectrum Asia - May 2022Add to Favorites

Magzter GOLDで読み攟題を利甚する

1 回の賌読で BioSpectrum Asia ず 8,500 およびその他の雑誌や新聞を読むこずができたす  カタログを芋る

1 ヶ月 $9.99

1 幎$99.99 $49.99

$4/ヶ月

保存 50% Hurry, Offer Ends in 5 Days
(OR)

のみ賌読する BioSpectrum Asia

1幎$11.88 $7.99

保存 33% Memorial Day Sale!. ends on June 1, 2024

この号を賌入 $0.99

ギフト BioSpectrum Asia

7-Day No Questions Asked Refund7-Day No Questions
Asked Refund Policy

 ⓘ

Digital Subscription.Instant Access.

Digital Subscription
Instant Access

ⓘ

Verified Secure Payment

怜蚌枈み安党
支払い

ⓘ

この問題で

Oz BUDGET BOLSTERS HEALTHCARE
Circumstances have continued to evolve as the COVID-19 Omicron variant has added further pressure to Australia’s healthcare sector, as well as increasing supply chain disruptions, bringing about staff shortages and reducing household spending. With a Federal election due on May 21, 2022 to elect members of the 47th Parliament of Australia, Josh Frydenberg , Treasurer of the Commonwealth of Australia presented the Federal Budget on March 29. The Coalition government
led by Scott Morrison is investing in a stronger health system as part of its plan for a stronger future through a record $132 billion in 2022–23 Budget, increasing to $140 billion in 2025–26, with a total commitment of $537 billion over the next four years. This record funding will ensure Australians have access to improved healthcare, when and where they need it, helping them to lead healthier lives, with improved health outcomes and to provide ongoing protection against COVID-19.

Japan approves Novavax's COVID-19 vaccine for primary, booster immunisation

COVID-19 Vaccine

Japan approves Novavax's COVID-19 vaccine for primary, booster immunisation

1 min

AmoyDx collaborates with AstraZeneca for multiple companion diagnostics in China

Amoy Diagnostics, a China based innovative molecular diagnostics company, has entered into a Master Collaboration Agreement with AstraZeneca.

AmoyDx collaborates with AstraZeneca for multiple companion diagnostics in China

1 min

Juniper Biologics offers world's first cell-mediated gene therapy for knee osteoarthritis

develop TG-C LD Juniper Biologics, a Singapore-based startup, has gained the licensing rights to and commercialize (TissueGene-C low dose) for the treatment of knee osteoarthritis.

Juniper Biologics offers world's first cell-mediated gene therapy for knee osteoarthritis

1 min

OZ BUDGET BOLSTERS HEALTHCARE

Circumstances have continued to evolve as the COVID-19 Omicron variant has added further pressure to Australia's healthcare sector, as well as increasing supply chain disruptions, bringing about staff shortages and reducing household spending.

OZ BUDGET BOLSTERS HEALTHCARE

10+ mins

Is On-Demand Healthcare Taking Off?

Digital healthcare is converging technology with healthcare to deliver more efficient, personalised, and innovative healthcare services through telemedicine, cloud-based mobile apps, wearable devices, clinical management devices, artificial intelligence, algorithm software, diagnostic medical devices, and more. Making use of the emerging opportunities, startups and Small and Medium Enterprises (SMEs) in Asia Pacific are accelerating their research, development, and production of emerging and disruptive technology tools. These small-scale innovators are gradually entering mainstream opportunities through collaboration with government, academics, and large industries for technological development as well as through partnership and investment opportunities. But, how far have they been successful in making a leap to thrive in the industry and overcoming the barriers? Let's dig deeper.

Is On-Demand Healthcare Taking Off?

10+ mins

Bringing patient voices into HTA, health policy development in Asia

Health technology assessment (HTA) is recognised as a crucial stage in the introduction of f new technology, new medicines, and new clinical practices.

Bringing patient voices into HTA, health policy development in Asia

6 mins

Japan Develops Photocatalyst For Antiviral Coating Against Covid-19

Viral infections mainly occur in indoor environments where many people gather.

Japan Develops Photocatalyst For Antiviral Coating Against Covid-19

1 min

Thermo Fisher introduces Gibco CTS TrueCut Cas9 Protein

Thermo Fisher Scientific has introduced the new GMP-manufactured Gibco CTS TrueCut Cas9 Protein.

Thermo Fisher introduces Gibco CTS TrueCut Cas9 Protein

1 min

BioSpectrum Asia の蚘事をすべお読む

BioSpectrum Asia Magazine Description:

出版瀟: MM Activ Sci-Tech Communication

カテゎリヌ: Business

蚀語: English

発行頻床: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.
* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.
* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.
* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.
* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.

  • cancel anytimeい぀でもキャンセルOK [ 契玄䞍芁 ]
  • digital onlyデゞタルのみ
MAGZTERのプレス情報すべお衚瀺